scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1470-2045(14)70293-1 |
P698 | PubMed publication ID | 24954804 |
P2093 | author name string | David H Ilson | |
P2860 | cites work | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 | ||
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | Q34634936 | ||
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets | Q35878807 | ||
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis | Q36205151 | ||
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer | Q43620764 | ||
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial | Q88132239 | ||
P433 | issue | 8 | |
P1104 | number of pages | 2 | |
P304 | page(s) | 788-789 | |
P577 | publication date | 2014-06-18 | |
P1433 | published in | Lancet Oncology Commission | Q13747613 |
P1476 | title | Adjuvant treatment for gastric cancer: too much is not enough | |
P478 | volume | 15 |
Q41549417 | Caragaphenol a induces reactive oxygen species related apoptosis in human gastric cancer cells |
Q64917579 | Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo. |
Q35870886 | Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy. |
Q92669041 | HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression |
Q36375276 | Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer |
Q36309435 | MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells |
Q41097111 | Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer |
Search more.